Announcements Trials
Browse Landscape

Phase

Phase 2 14Phase 1 14Phase 1/2 7Phase NA 3Phase 3 3

Status

Completed 2Unknown 1

Sponsor Class

OTHER 2INDUSTRY 1

Study Type

Interventional 3

Sponsor

Cancer Type

Genitourinary 3Sarcoma 1Other solid neoplasm 1Head & Neck 1

Conditions

Prostatic Neoplasms 1Kidney Neoplasms 1Carcinoma, Renal Cell 1

Interventions

Radiosurgery 73Magnetic Resonance Spectroscopy 48Standard of Care 41Radiotherapy 36Exercise 36Blood Specimen Collection 28Early Intervention, Educational 26Surveys and Questionnaires 24Multiparametric Magnetic Resonance Imaging 22Magnetic Resonance Imaging 21Brachytherapy 21Androgen Antagonists 20Methods 19Therapeutics 18Radiotherapy, Intensity-Modulated 18Interviews as Topic 18Cystectomy 16Educational Status 15Biopsy 15Psychiatric Rehabilitation 14Practice Guidelines as Topic 14Diet Therapy 14Sunitinib 12Specimen Handling 12Resistance Training 12gallium 68 PSMA-11 11Radiation 11Watchful Waiting 9Surgical Procedures, Operative 9Proton Therapy 9

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase NA × temsirolimus × Genitourinary × Clear all
NCT03571438 2020-01-18

COMBOREIN

University Hospital, Grenoble

Phase NA Unknown
100 enrolled
Genitourinary

Kidney Neoplasms

NCT01404104 2016-07-27

Neo-adjuvant Temsirolimus in Patients With Advanced Renal Cell Carcinoma

St. Joseph's Healthcare Hamilton

Phase NA Completed
11 enrolled
Genitourinary

Carcinoma, Renal Cell

NCT00235794 2007-12-27

An Open Label Exploratory Study in Newly Diagnosed Prostate Cancer Patients

Wyeth is now a wholly owned subsidiary of Pfizer

Phase NA Completed
50 enrolled
Genitourinary

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡